Skip to main content

Mehrotra Parth's Form 4 filing

Privia Health Group, Inc. (PRVA) · filed Sep 12, 2024

Accession no.
0001759655-24-000125
Filed
Sep 12, 2024
Trade date
Sep 10-11, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 7 non-derivative transactions and 6 derivative transactions. Open-market sales total $2.50M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mehrotra ParthCIK 0001858398Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 10, 2024Common Stock, $0.01 par value per shareMOption exerciseAcquired+56,027$2.00+$112,054303,798Direct
Sep 10, 2024Common Stock, $0.01 par value per shareMOption exerciseAcquired+60,520$2.00+$121,040364,318Direct
Sep 10, 2024Common Stock, $0.01 par value per shareMOption exerciseAcquired+18,595$2.00+$37,190382,913Direct
Sep 10, 2024Common Stock, $0.01 par value per shareSSaleDisposed−135,142$18.50F2−$2,500,127247,771Direct
Sep 11, 2024Common Stock, $0.01 par value per shareMOption exerciseAcquired+48,645$2.00+$97,290296,416Direct
Sep 11, 2024Common Stock, $0.01 par value per shareMOption exerciseAcquired+52,546$2.00+$105,092348,962Direct
Sep 11, 2024Common Stock, $0.01 par value per shareMOption exerciseAcquired+16,144$2.00+$32,288365,106Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 10, 2024Common Stock, $0.01 par value per shareMOption exerciseDisposed−56,027$0.00$048,645Direct
Sep 10, 2024Common Stock, $0.01 par value per shareMOption exerciseDisposed−60,520$0.00$052,546Direct
Sep 10, 2024Common Stock, $0.01 par value per shareMOption exerciseDisposed−18,595$0.00$016,144Direct
Sep 11, 2024Common Stock, $0.01 par value per shareMOption exerciseDisposed−48,645$0.00$00Direct
Sep 11, 2024Common Stock, $0.01 par value per shareMOption exerciseDisposed−52,546$0.00$00Direct
Sep 11, 2024Common Stock, $0.01 par value per shareMOption exerciseDisposed−16,144$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.37 to $18.73 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)